|
1
|
Gartry DS, Chignell AH, Franks WA and Wong
D: Pars plana vitrectomy for the treatment of rhegmatogenous
retinal detachment uncomplicated by advanced proliferative
vitreoretinopathy. Br J Ophthalmol. 77:199–203. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Leiderman YI and Miller JW: Proliferative
vitreoretinopathy: Pathobiology and therapeutic targets. Semin
Ophthalmol. 24:62–69. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pastor JC, de la Rúa ER and Martín F:
Proliferative vitreoretinopathy: Risk factors and pathobiology.
Prog Retin Eye Res. 21:127–144. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yu J, Liu F, Cui SJ, Liu Y, Song ZY, Cao
H, Chen FE, Wang WJ, Sun T and Wang F: Vitreous proteomic analysis
of proliferative vitreoretinopathy. Proteomics. 8:3667–3678. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kurimoto R, Iwasawa S, Ebata T, Ishiwata
T, Sekine I, Tada Y, Tatsumi K, Koide S, Iwama A and Takiguchi Y:
Drug resistance originating from a TGF-β/FGF-2-driven
epithelial-to-mesenchymal transition and its reversion in human
lung adenocarcinoma cell lines harboring an EGFR mutation. Int J
Oncol. 48:1825–1836. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim J, Kong J, Chang H, Kim H and Kim A:
EGF induces epithelial-mesenchymal transition through
phospho-Smad2/3-Snail signaling pathway in breast cancer cells.
Oncotarget. 7:85021–85032. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Garweg JG, Tappeiner C and Halberstadt M:
Pathophysiology of proliferative vitreoretinopathy in retinal
detachment. Surv Ophthalmol. 58:321–329. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lamouille S and Derynck R: Cell size and
invasion in TGF-beta-induced epithelial to mesenchymal transition
is regulated by activation of the mTOR pathway. J Cell Biol.
178:437–451. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Charteris DG: Proliferative
vitreoretinopathy: Pathobiology, surgical management, and
adjunctive treatment. Br J Ophthalmol. 79:953–960. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li M, Li H, Liu X, Xu D and Wang F:
MicroRNA-29b regulates TGF-β1-mediated epithelial-mesenchymal
transition of retinal pigment epithelial cells by targeting AKT2.
Exp Cell Res. 345:115–124. 2016. View Article : Google Scholar
|
|
11
|
Yao H, Li H, Yang S, Li M, Zhao C, Zhang
J, Xu G and Wang F: Inhibitory effect of bone morphogenetic protein
4 in retinal pigment epithelial-mesenchymal transition. Sci Rep.
2:321822016. View Article : Google Scholar
|
|
12
|
Martin H: Role of PPAR-gamma in
inflammation. Prospects for therapeutic intervention by food
components. Mutat Res. 690:57–63. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chou HC, Wen LL, Chang CC, Lin CY, Jin L
and Juan SH: From the Cover: l-Carnitine via PPARγ- and
Sirt1-dependent mechanisms attenuates epithelial-mesenchymal
transition and renal fibrosis caused by perfluorooctanesulfonate.
Toxicol Sci. 160:217–229. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ferguson HE, Kulkarni A, Lehmann GM,
Garcia-Bates TM, Thatcher TH, Huxlin KR, Phipps RP and Sime PJ:
Electrophilic peroxisome proliferator-activated receptor-gamma
ligands have potent antifibrotic effects in human lung fibroblasts.
Am J Respir Cell Mol Biol. 41:722–730. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kao HF, Chang-Chien PW, Chang WT, Yeh TM
and Wang JY: Propolis inhibits TGF-β1-induced
epithelial-mesenchymal transition in human alveolar epithelial
cells via PPARγ activation. Int Immunopharmacol. 15:565–574. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fang IM, Yang CH and Yang CM:
Docosahexaenoic acid reduces linoleic acid induced monocyte
chemoattractant protein-1 expression via PPARγ and nuclear
factor-κB pathway in retinal pigment epithelial cells. Mol Nutr
Food Res. 58:2053–2065. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Willermain F, Dulku S, Gonzalez NS, Blero
D, Driessens G, De Graef C, Caspers L and Bruyns C:
15-Deoxy-12,14-prostaglandin J2 inhibits interferon gamma induced
MHC class II but not class I expression on ARPE cells through a
PPAR gamma independent mechanism. Prostaglandins Other Lipid
Mediat. 80:136–143. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rolim LC, da Silva EM, Flumignan RL, Abreu
MM and Dib SA: Acetyl-L-carnitine for the treatment of diabetic
peripheral neuropathy. Cochrane Database Syst Rev.
6:CD0112652019.PubMed/NCBI
|
|
19
|
Li M, Li H, Jiang P, Liu X, Xu D and Wang
F: Investigating the pathological processes of rhegmatogenous
retinal detachment and proliferative vitreoretinopathy with
metabolomics analysis. Mol Biosyst. 10:1055–1062. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Baci D, Bruno A, Bassani B, Tramacere M,
Mortara L, Albini A and Noonan DM: Acetyl-L-carnitine is an
anti-angiogenic agent targeting the VEGFR2 and CXCR4 pathways.
Cancer Lett. 429:100–116. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zambrano S, Blanca AJ, Ruiz-Armenta MV,
Miguel-Carrasco JL, Arévalo M, Mate A and Vázquez CM: L-carnitine
attenuates the development of kidney fibrosis in hypertensive rats
by upregulating PPAR-γ. Am J Hypertens. 27:460–470. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Parapuram SK, Ganti R, Hunt RC and Hunt
DM: Vitreous induces components of the prostaglandin E2
pathwayaglandin E2 pathway in human retinal pigment epithelial
cells. Invest Ophthalmol Vis Sci. 44:1767–1774. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
24
|
Chen Z, Mei Y, Lei H, Tian R, Ni N, Han F,
Gan S and Sun S: LYTAK1, a TAK1 inhibitor, suppresses proliferation
and epithelial-mesenchymal transition in retinal pigment epithelium
cells. Mol Med Rep. 14:145–150. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ishikawa H, Takaki A, Tsuzaki R, Yasunaka
T, Koike K, Shimomura Y, Seki H, Matsushita H, Miyake Y, Ikeda F,
et al: L-carnitine prevents progression of non-alcoholic
steatohepatitis in a mouse model with upregulation of mitochondrial
pathway. PLoS One. 9:e1006272014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ferreira GC and McKenna MC: L-Carnitine
and Acetyl-L-carnitine roles and neuroprotection in developing
brain. Neurochem Res. 42:1661–1675. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Blanca AJ, Ruiz-Armenta MV, Zambrano S,
Miguel-Carrasco JL, Arias JL, Arévalo M, Mate A, Aramburu O and
Vázquez CM: Inflammatory and fibrotic processes are involved in the
cardiotoxic effect of sunitinib: Protective role of L-carnitine.
Toxicol Lett. 241:9–18. 2016. View Article : Google Scholar
|
|
28
|
Ling G, Ji Q, Ye W, Ma D and Wang Y:
Epithelial-mesenchymal transition regulated by p38/MAPK signaling
pathways participates in vasculogenic mimicry formation in SHG44
cells transfected with TGF-β cDNA loaded lentivirus in vitro and in
vivo. Int J Oncol. 49:2387–2398. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Park JH, Yoon J, Lee KY and Park B:
Effects of geniposide on hepatocytes undergoing
epithelial-mesenchymal transition in hepatic fibrosis by targeting
TGFβ/Smad and ERK-MAPK signaling pathways. Biochimie. 113:26–34.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhou X, Kuang X, Long C, Liu W, Tang Y,
Liu L, Liu H, He J, Huang Z, Fan Y, et al: Curcumin inhibits
proliferation and epithelial-mesenchymal transition of retinal
pigment epithelial cells via multiple pathways. Curr Mol Med.
17:312–319. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhou BY, Buckley ST, Patel V, Liu YX, Luo
J, Krishnaveni MS, Ivan M, DeMaio L, Kim KJ, Ehrhardt C, et al:
Troglitazone attenuates TGF-β1-induced EMT in alveolar epithelial
cells via a PPARγ-independent mechanism. PLoS One. 7:e388272012.
View Article : Google Scholar
|
|
32
|
Han D, Wu G, Chang C, Zhu F, Xiao Y, Li Q,
Zhang T and Zhang L: Disulfiram inhibits TGF-β-induced
epithelial-mesenchymal transition and stem-like features in breast
cancer via ERK/NF-κB/Snail pathway. Oncotarget. 6:40907–40919.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cho IH, Jang EH, Hong D, Jung B, Park MJ
and Kim JH: Suppression of LPS-induced epithelial-mesenchymal
transition by aqueous extracts of Prunella vulgaris through
inhibition of the NF-κB/Snail signaling pathway and regulation of
EMT-related protein expression. Oncol Rep. 34:2445–2450. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li H, Li M, Xu D, Zhao C, Liu G and Wang
F: Overexpression of Snail in retinal pigment epithelial triggered
epithelial-mesenchymal transition. Biochem Biophys Res Commun.
446:347–351. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li H, Chang HM, Shi Z and Leung PCK: SNAIL
mediates TGF-β1-induced downregulation of pentraxin 3 expression in
human granulosa cells. Endocrinology. 159:1644–1657. 2018.
View Article : Google Scholar : PubMed/NCBI
|
